Deflux

Type: Product
Name: Deflux
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

SALIX PHARMACEUTICALS : Updates on Second Quarter Results

Salix Pharmaceuticals reported financial and operating results for the second quarter ended June 30 , and provided other business updates.In an August 7 release, the company noted that key financial highlights include:-Results for the first six months ... [Published 4 Traders - Aug 19 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Salix Pharmaceuticals Posts Second Quarter Results

Salix Pharmaceuticals reported financial and operating results for the second quarter ended June 30, and provided other business updates. In an August 7 release, the company noted that key financial highlights include:-Results for the first six months ... [Published Individual.com - Aug 14 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 2 reports

Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance

The share price of Salix Pharmaceuticals, Ltd. ( SLXP - Analyst Report ) fell 3.9% after the company announced its second-quarter results on Aug 7. Although share prices have recovered slightly, the stock is still down 3.6%.Salix posted second quarter ... [Published Zacks.com - Aug 12 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Endoscopic treatment of symptomatic vesicoureteral reflux after renal transplantation - Abstract

PURPOSE: To evaluate the success of endoscopic treatment of symptomatic vesicoureteral reflux (VUR) after renal transplantation and to identify the predictive factors of success.MATERIALS AND METHODS: Between January 2000 and December 2010, 58 patients ... [Published UroToday - Aug 12 2014]

Quotes

Adam Derbyshire , Executive Vice President and Chief Financial Officer, stated, "We continue to see considerable momentum in our business, which we expect to accelerate through the second half of the year. We have achieved several key milestones over the last several months, our new sales infrastructure is beginning to gain traction and prescriptions for our key products are growing. Our third quarter outlook reflects our expectation for some adjustments in the supply chain to continue into the quarter as wholesalers more closely manage inventory levels. However, we expect to see a strong fourth quarter, which historically has been our strongest quarter, as the business continues to realize the combined impact of strong prescription growth and rising productivity of our new digestive disease sales force."
...event for Salix and an important milestone in its growth as the leading gastroenterology-focused specialty pharmaceutical company in the US. "The creation of a larger, stronger Salix reinforces our premier position in gastroenterology and creates the opportunity for us to expand our digestive disease expertise into other key specialties" Logan added. Latest News

More Content

All (8) | News (6) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (2) | Press Releases (0)
sort by: Date | Relevance
SALIX PHARMACEUTICALS : Updates on Second Quart... [Published 4 Traders - Aug 19 2014]
Salix Pharmaceuticals Posts Second Quarter Results [Published Individual.com - Aug 14 2014]
Salix Pharmaceuticals Beats on Q2 Earnings, Cut... [Published Zacks.com - Aug 12 2014]
Salix Pharmaceuticals Posts Second Quarter 2014... [Published PredictWallStreet - Aug 12 2014]
Endoscopic treatment of symptomatic vesicourete... [Published UroToday - Aug 12 2014]
Salix Pharmaceuticals completes $2.6bn acquisit... [Published Pharmaceutical Business Review - Jan 03 2014]
Fact Sheet for Q-Med AB [Published Able2Act - Jul 16 2008]
Fact Sheet for Q-Med [Published Able2Act - Feb 12 2008]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.